What does stable disease mean on my Kidney Cancer scan results

Understanding "Stable Disease" in Your Kidney Cancer Scan Results

Great question—this is an important finding to understand. Let me explain what "stable disease" means and why it matters for your care.

What Stable Disease Means

Stable disease means your tumors are not growing and not shrinking on your most recent scan compared to your previous scan. The size and extent of your kidney cancer have remained essentially the same.

This is measured using standardized criteria called RECIST (Response Evaluation Criteria in Solid Tumors), which doctors use to track how your cancer is responding to treatment. According to the medical literature on cancer response assessment, stable disease falls into a specific category:

• Shrinking tumors = Good response (called "partial response")
• Stable disease = No significant change
• Growing tumors = Disease progression

Why Stable Disease Can Actually Be Beneficial

Here's something important that often gets overlooked: stable disease is NOT the same as treatment failure.

As cancer expert Chris Beardmore explains in the CancerPatientLab webinar "Getting Access to Your Cancer Treatment," the medical community is reconsidering how we evaluate disease progression. He points out that slow progression or stable disease can be genuinely beneficial, especially when you consider:

1. Quality of life matters - If your disease stays stable while you maintain good quality of life, that's a meaningful win
2. Buying time - Stable disease gives your body time while new, potentially better therapies become available
3. Better than progression - Stopping your cancer from growing is a real achievement, even if it's not shrinking

Beardmore notes that doctors sometimes see patients with stable disease and continue treatment because they recognize that "slow progression is better than unfettered disease progression."

Questions to Ask Your Oncologist

Since you have stable disease, here are specific questions to discuss with your kidney cancer team:

1. "How does my current scan compare to my previous scan—are the tumors exactly the same size, or is there any slight change?" (This helps you understand the degree of stability)

2. "What treatment am I currently on, and does stable disease mean we should continue this approach?" (For kidney cancer, this might be immunotherapy, targeted therapy like VEGF inhibitors, or other options)

3. "How often will we scan to monitor for any changes?" (Typical monitoring might be every 8-12 weeks, depending on your situation)

4. "If my disease remains stable, what's the long-term plan?" (Some patients stay on current treatment; others may have planned treatment breaks)

5. "Are there any clinical trials available that might be appropriate if my disease progresses?" (This helps you plan ahead)

Important Context for Kidney Cancer

For kidney cancer specifically, according to NCCN (National Comprehensive Cancer Network) Guidelines, treatment decisions depend on factors like:

• Your disease stage and whether it's metastatic (spread)
• Your overall health and kidney function
• Which biomarkers your tumor has (like PD-L1 status)
• Your previous treatments

Stable disease on your current treatment is often considered a reasonable outcome, and your oncologist will use this information to decide whether to continue, modify, or change your approach.

The Bottom Line

Stable disease means your treatment is holding your cancer in check—preventing it from growing. While it's not a shrinking response, it's a meaningful result that buys you time and maintains your quality of life. This is especially important in kidney cancer, where some patients live for years with stable disease on appropriate treatment.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about your specific scan results and treatment plan.